Resources
Filter by Topic
- Articles
Joseph Menzin, PhD, discusses the risks and rewards of fast-tracked COVID-19 studies.
- Press Releases
BHE, a leading healthcare analytics company, has announced the formation of its Strategic Advisory Board. The initial appointments include Peter Neumann, ScD, Director of the...
- Articles
Matthew Sussman, BHE's VP of Modeling & Strategy Services, discusses the use of remdesivir for COVID-19 patients and the risks and rewards of fast tracking...
- News & Events
Matthew Sussman, BHE's VP of Modeling & Strategy Services, discusses exploring strategies for facilitating access to the timely patient data and analysis needed for successful...
- News & Events
We formed a partnership with Premier Inc. to streamline data analytics and more quickly uncover strategies to improve patient care. Researchers and data scientists will...
- Press Releases
Boston Health Economics (BHE), a leading healthcare self-service analytics company, and Premier Healthcare Solutions, Inc. (Premier), a leading healthcare improvement company, are joining forces to...
- Articles
Healthcare IT Today article from Panalgo Founder and Executive Chairman, Joseph Menzin, PhD.
Worries and Hopes for Healthcare Delivery in 2024
Industry experts from Norstella – a family of brands that includes, Citeline, the Dedham Group, Evaluate, MMIT, and Panalgo, and whose data and technologies support
Building Effective Real World Evidence Studies to Support New Indications for Established Products
In this article from PharmExec.com, Panalgo’s Executive Director of Solutions Meg Richards, and Dr. Samy Suissa, Founder of the Canadian Network for Observational Drug Effect
Leaning Into RWE: The IRA is Here, So Now’s the Time
Manufacturers are continuing to wrestle with the effects of the Inflation Reduction Act (IRA) on their business plans and revenue streams. Although some of the
Conclusions from Copenhagen: Highlights of ISPOR EU 2023
ISPOR Europe 2023, with the largest number of delegates on record (5,600) was held in wonderful, wonderful Copenhagen (cue the Danny Kaye waltz) last week.
How RWE Improves Evidence Generation Across the Product Life Cycle
Real-world evidence (RWE) is crucial for biopharmaceutical companies and other life sciences organizations to develop the right products for the marketplace. RWE is a powerful
Linking Real-World Data is Like Making a Fine, Blended Wine
In the healthcare and life sciences industries, developments like the explosion of real-world data, new regulatory programs and frameworks, and a focus on AI and
IHD Analytics
Put reliable, rapid analytics in the hands of more people across your organization